Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multinomial logistic regression analysis for differentiating 3 treatment outcome trajectory groups for

Kristin Nicole Lewis1, Bernadette Davantes Heckman, Lina Himawan

  • 1Department of Psychology, Ohio University, Athens, OH, USA.

Pain
|March 23, 2011
PubMed
Summary

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Health Indicators as Measures of Individual Health Status, Their Perceived Importance, and Associated Factors: Cross-Sectional Observational Study.

JMIR public health and surveillance·2025
Same author

Preliminary data that psychological treatment and baseline anxiety are associated with a decrease in postprandial fullness and early satiation for individuals with bulimia nervosa and related other specified feeding or eating disorder.

The International journal of eating disorders·2023
Same author

Health Indicators as Measures of Individual Health Status and Their Public Perspectives: Cross-sectional Survey Study.

Journal of medical Internet research·2022
Same author

The Effect of Pain Resilience on Experimental Pain Experience Across Different Stimuli.

Psychosomatic medicine·2020
Same author

Availability and usage of clinical decision support systems (CDSSs) in office-based primary care settings in the USA.

BMJ health & care informatics·2019
Same author

Enhancing psychotherapy process with common factors feedback: A randomized, clinical trial.

Journal of counseling psychology·2017

Growth mixture modeling identified distinct patient groups for headache disability treatment. Attendance significantly impacts outcomes, suggesting targeted interventions for better headache management.

Area of Science:

  • Neurology
  • Clinical Psychology
  • Health Services Research

Background:

  • Headache disability significantly impacts patient quality of life.
  • Identifying patient subgroups with distinct treatment trajectories is crucial for personalized care.

Purpose of the Study:

  • To identify latent groups based on headache disability outcome trajectories.
  • To determine predictors of treatment success in headache subspecialty clinics.

Main Methods:

  • Longitudinal study design with 219 patients in headache subspecialty clinics.
  • Growth mixture modeling (GMM) to identify treatment outcome trajectories.
  • Multinomial logistic regression to identify significant predictors.

Main Results:

Related Experiment Videos

  • Three distinct trajectory groups were identified: high-disability improvers (11%), high-disability nonimprovers (34%), and moderate-disability improvers (55%).
  • Treatment appointment attendance was a significant predictor differentiating high-disability improvers from nonimprovers.
  • Approximately 75% of high-disability patients did not show reduced disability after 5 months of preventive pharmacotherapy.

Conclusions:

  • Preventive headache pharmacotherapies appear most effective for patients with moderate disability.
  • High-disability patients benefit most when they attend all treatment appointments.
  • Optimizing treatment adherence is critical for improving outcomes in high-disability headache patients.